Masimo Co. (NASDAQ: MASI) shares acquired by the Arizona State Retirement System
Arizona State Retirement System increased its holdings of Masimo Co. (NASDAQ:MASI – Get Rating) stock 2.5% in Q1, according to its latest 13F filing with the Securities and Exchange Commission. The institutional investor held 14,603 shares of the medical equipment supplier after acquiring 362 additional shares during the quarter. Arizona State Retirement System’s holdings in Masimo were worth $2,125,000 when it last filed with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also changed their positions in the company. Comerica Bank increased its stake in Masimo by 3.4% in the first quarter. Comerica Bank now owns 23,749 shares of the medical equipment supplier worth $3,235,000 after buying an additional 786 shares last quarter. Arkadios Wealth Advisors acquired a new position in Masimo in Q1 worth $213,000. Robeco Institutional Asset Management BV increased its stake in Masimo by 73.8% in the fourth quarter. Robeco Institutional Asset Management BV now owns 4,619 shares of the medical equipment supplier worth $1,353,000 after buying an additional 1,961 shares last quarter. Itau Unibanco Holding SA acquired a new position in Masimo in Q4 worth $80,000. Finally, Astrantus Ltd acquired a new position in Masimo in Q4 worth $339,000. Institutional investors and hedge funds own 92.03% of the company’s shares.
Masimo shares down 0.4%
NASDAQ:MASI shares opened at $144.58 on Monday. Masimo Co. has a fifty-two week low of $112.07 and a fifty-two week high of $305.21. The company has a 50-day simple moving average of $135.68 and a 200-day simple moving average of $152.51. The company has a market capitalization of $8.02 billion, a PE ratio of 37.36 and a beta of 0.98.
Masimo (NASDAQ:MASI – Get Rating) last reported quarterly earnings data on Tuesday, May 3. The medical equipment supplier reported earnings per share of $0.93 for the quarter, beating consensus analyst estimates of $0.92 by $0.01. Masimo had a net margin of 17.91% and a return on equity of 15.46%. The company posted revenue of $304.24 million in the quarter, versus a consensus estimate of $308.04 million. During the same quarter of the previous year, the company achieved EPS of $0.90. The company’s revenue for the quarter increased by 1.7% compared to the same quarter last year. As a group, research analysts expect Masimo Co. to post EPS of 4.61 for the current fiscal year.
Wall Street analysts predict growth
A number of brokerages have commented on MASI. StockNews.com upgraded Masimo shares from a “hold” rating to a “buy” rating in a Wednesday, July 13 report. Needham & Company LLC lowered its target price on Masimo shares from $205.00 to $163.00 in a Wednesday May 4 research report. Piper Sandler lowered its price target on Masimo shares from $160.00 to $130.00 in a Wednesday May 4 research report. Stifel Nicolaus lowered his price target on Masimo shares from $175.00 to $150.00 in a Wednesday May 4 research report. Finally, Wolfe Research began covering Masimo shares in a research report on Tuesday, April 5. They issued a “market performance” rating and a target price of $160.00 for the company. Three analysts gave the stock a hold rating and four gave the company a buy rating. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $179.60.
(Get a rating)
Masimo Corporation develops, manufactures and markets noninvasive monitoring technologies and hospital automation solutions worldwide. Company offers pulse oximetry based on Masimo Signal Extraction Technology (SET) with measurement through motion and low perfusion pulse oximetry monitoring to address key limitations of conventional pulse oximetry .
Get news and reviews for Masimo Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Masimo and related companies with MarketBeat.com’s free daily email newsletter.